CVS Health Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss decreased by 22.5% to $307.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 31.2%, from $446.00M to $307.00M. Over 4 years (FY 2020 to FY 2024), Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss shows an upward trend with a 390.7% CAGR.
other_debt_securities_available_for_sale_continuous_unre_23ad4c| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.00M | $6.00M | $22.00M | $103.00M | $148.00M | $439.00M | $614.00M | $1.11B | $1.20B | $1.50B | $808.00M | $826.00M | $799.00M | $446.00M | $580.00M | $476.00M | $396.00M | $307.00M |
| QoQ Change | — | +500.0% | +266.7% | +368.2% | +43.7% | +196.6% | +39.9% | +80.0% | +9.0% | +24.7% | -46.2% | +2.2% | -3.3% | -44.2% | +30.0% | -17.9% | -16.8% | -22.5% |
| YoY Change | — | — | — | — | >999% | >999% | >999% | +972.8% | +713.5% | +241.9% | +31.6% | -25.2% | -33.6% | -70.3% | -28.2% | -42.4% | -50.4% | -31.2% |